This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Corticosteroid

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Corticosteroids are a group of drugs commonly referred to as steroids, though they are not to be confused with anabolic or other steroids.[1] These steroids are synthetic or naturally occurring versions of the hormones produced by the adrenal glands.[1] [2]

Usage[edit | edit source]

Corticosteroids have many different uses, including autoimmune conditions like rheumatoid arthritis or lupus, plus many other conditions like localized joint pain, COPD and asthma.[1][3]

Drugs[edit | edit source]

Corticosteroids drugs include hydrocortisone, fludrocortisone, glucocorticoid, betamethasone and dexamethasone.[2]

Glucocorticoids and mineralcorticoids[edit | edit source]

Corticosteroid drugs have different degrees of glucocorticoid or mineralcorticoid effects, or a mix of both.[2] Glucocorticoid effects generally involve "regulating metabolism, and inflammation." Mineralcorticoid effects generally involve "regulating sodium and water levels", and side effects may include increased excretion of potassium.[2] Fludrocortisone has strong mineralcorticoid effects, and may be used for orthostatic intolerance.

Glucocorticoid drugs, including prednisone, can have psychiatric side effects and cause bone problems, including glucocorticoid induced osteoporosis.[3]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. Jump up to: 1.0 1.1 1.2 National Health Service. "Steroids". NICE. Retrieved May 2, 2019.
  2. Jump up to: 2.0 2.1 2.2 2.3 Ericson-Neilsen, William; Kaye, Alan David (2014). "Steroids: Pharmacology, Complications, and Practice Delivery Issues". The Ochsner Journal. 14 (2): 203–207. ISSN 1524-5012. PMC 4052587. PMID 24940130.
  3. Jump up to: 3.0 3.1 Yoshitomi, Hisae; Iwaoka, Emiko; Kubo, Masahide; Shibata, Masaru; Gao, Ming (January 2011). "Beneficial effect of Sparassis crispa on stroke through activation of Akt/eNOS pathway in brain of SHRSP". Journal of Natural Medicines. 65 (1): 135–141. doi:10.1007/s11418-010-0475-9. ISSN 1340-3443. PMC 2999729. PMID 21076883.